- Report
- September 2026
- 181 Pages
Global
From €3291EUR$3,545USD£2,747GBP
€3656EUR$3,939USD£3,052GBP
- Report
- September 2026
- 188 Pages
Global
From €3291EUR$3,545USD£2,747GBP
€3656EUR$3,939USD£3,052GBP
- Report
- November 2026
- 386 Pages
Global
From €5430EUR$5,850USD£4,533GBP
- Report
- February 2026
- 250 Pages
Global
From €4168EUR$4,490USD£3,479GBP
- Report
- February 2026
- 250 Pages
Global
From €4168EUR$4,490USD£3,479GBP
- Report
- February 2026
- 250 Pages
Global
From €4168EUR$4,490USD£3,479GBP
- Report
- May 2026
- 436 Pages
Global
From €4168EUR$4,490USD£3,479GBP
- Report
- January 2026
- 185 Pages
Global
From €4177EUR$4,500USD£3,487GBP
- Report
- February 2026
- 250 Pages
Global
From €4168EUR$4,490USD£3,479GBP
- Report
- August 2026
- 122 Pages
Global
From €4409EUR$4,750USD£3,681GBP
- Report
- February 2026
- 172 Pages
Global
From €4502EUR$4,850USD£3,758GBP
- Report
- August 2026
- 160 Pages
Global
From €3082EUR$3,320USD£2,573GBP
€3852EUR$4,150USD£3,216GBP
- Report
- January 2026
- 169 Pages
Global
From €4316EUR$4,650USD£3,603GBP
- Report
- May 2021
- 177 Pages
United States
€1388EUR$1,495USD£1,158GBP
- Report
- February 2025
- 100 Pages
Global
From €5523EUR$5,950USD£4,611GBP
- Report
- January 2024
- 200 Pages
Global
From €3852EUR$4,150USD£3,216GBP
- Report
- October 2023
- 145 Pages
Global
From €2924EUR$3,150USD£2,441GBP
- Report
- June 2025
- 233 Pages
Global
From €2320EUR$2,500USD£1,937GBP
- Report
- October 2022
- 119 Pages
Global
From €4177EUR$4,500USD£3,487GBP
- Report
- March 2025
- 290 Pages
Global
From €4168EUR$4,490USD£3,479GBP

The Insomnia Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Insomnia drugs are used to treat difficulty sleeping, and can be divided into two categories: sedative-hypnotics and non-sedative hypnotics. Sedative-hypnotics are drugs that act on the central nervous system to induce sleep, while non-sedative hypnotics are drugs that act on the brain to improve sleep quality without causing sedation. Commonly prescribed insomnia drugs include benzodiazepines, non-benzodiazepines, and melatonin receptor agonists.
Some companies in the Insomnia Drug market include Sanofi, Pfizer, Merck, GlaxoSmithKline, and Takeda. Show Less Read more